Akumentis Healthcare launches Clasepi, synthetic CBD for epilepsy EP News Bureau Jan 10, 2024 Clasepi comes with important usage considerations; it is not recommended for individuals allergic to cannabidiol or any of its…
Novartis’ Afinitor reduces seizures in patients with tuberous sclerosis complex EP News Bureau Apr 22, 2016 Results presented at American Academy of Neurology will be discussed with health authorities for potential worldwide regulatory…
